Embolotherapy Market Research Report by Product, Disease Indication, Procedure, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Embolotherapy Market size was estimated at USD 3,728.60 million in 2021 and expected to reach USD 4,050.36 million in 2022, and is projected to grow at a CAGR 8.80% to reach USD 6,186.88 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Embolotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Embolic Agents and Support Devices. The Embolic Agents is further studied across Detachable Balloons, Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, and Microspheres. The Support Devices is further studied across Guidewires and Microcatheters.

Based on Disease Indication, the market was studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.

Based on Procedure, the market was studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy.

Based on End User, the market was studied across Ambulatory Surgery Centers and Hospitals and Clinics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Embolotherapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Embolotherapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Embolotherapy Market, including Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, BTG plc, Cook Medical Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc, Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Embolotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Embolotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Embolotherapy Market?
4. What is the competitive strategic window for opportunities in the Global Embolotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global Embolotherapy Market?
6. What is the market share of the leading vendors in the Global Embolotherapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Embolotherapy Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing target patient population
5.1.1.2. Rising patient preference for minimally invasive procedures
5.1.1.3. Investment & funding by government and private organizations
5.1.1.4. Technology advancements in embolotherapy devices
5.1.1.5. Favorable reimbursement scenario for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
5.1.2.2. Strong market positioning of alternative therapies
5.1.3. Opportunities
5.1.3.1. Growth opportunities in emerging markets
5.1.3.2. Expanding applications of embolization devices
5.1.4. Challenges
5.1.4.1. Lack of skilled surgeons
5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
5.2. Cumulative Impact of COVID-19

6. Embolotherapy Market, by Product
6.1. Introduction
6.2. Embolic Agents
6.3.1. Detachable Balloons
6.3.2. Embolic Coils
6.3.3. Embolic Plug Systems
6.3.4. Liquid Embolic Agents
6.3.5. Microspheres
6.3. Support Devices
6.4.1. Guidewires
6.4.2. Microcatheters

7. Embolotherapy Market, by Disease Indication
7.1. Introduction
7.2. Cancer
7.3. Gastrointestinal Disorders
7.4. Neurological Diseases
7.5. Peripheral Vascular Disease
7.6. Urological & Nephrological Disorders

8. Embolotherapy Market, by Procedure
8.1. Introduction
8.2. Transarterial Chemoembolization
8.3. Transcatheter Arterial Embolization
8.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9. Embolotherapy Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals and Clinics

10. Americas Embolotherapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Embolotherapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Embolotherapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Acandis GmbH
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Balt Extrusion
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Boston Scientific Corporation
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BTG plc
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cook Medical Incorporated
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Johnson & Johnson
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Kaneka Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Medtronic plc
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Meril Life Sciences Pvt., Ltd.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Merit Medical Systems Inc
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Penumbra, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Sirtex Medical Limited
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Stryker Corporation
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Terumo Corporation
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing